nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.04.2009 | Focus on

SUV and segmentation: pressing challenges in tumour assessment and treatment

verfasst von: Giovanni Lucignani

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Excerpt

“Measure what is measurable, and make measurable what is not so.”

Galileo Galilei (1564–1642)

…

Lucignani G, Paganelli G, Bombardieri E. The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective. Nucl Med Commun 2004;25 7:651–6.PubMedCrossRef

Benz MR, Evilevitch V, Allen-Auerbach MS, Eilber FC, Phelps ME, Czernin J, et al. Treatment monitoring by ¹⁸F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors. J Nucl Med 2008;49 7:1038–46.PubMedCrossRef

Mawlawi O, Townsend DW. Multimodality imaging: an update on PET/CT technology. Eur J Nucl Med Mol Imaging. 2008 Dec 23. doi:10.1007/s00259-008-1016-6

Aristophanous M, Penney BC, Pelizzari CA. The development and testing of a digital PET phantom for the evaluation of tumor volume segmentation techniques. Med Phys 2008;35 7:3331–42.PubMedCrossRef

Nwogu I, Corso JJ. Exploratory identification of image-based biomarkers for solid mass pulmonary tumors. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv 2008;11 Pt 1:612–9.PubMed

South CP, Partridge M, Evans PM. A theoretical framework for prescribing radiotherapy dose distributions using patient-specific biological information. Med Phys 2008;35 10:4599–611.PubMedCrossRef

Li H, Thorstad WL, Biehl KJ, Laforest R, Su Y, Shoghi KI, et al. A novel PET tumor delineation method based on adaptive region-growing and dual-front active contours. Med Phys 2008;35 8:3711–21.PubMedCrossRef

Brambilla M, Matheoud R, Secco C, Loi G, Krengli M, Inglese E. Threshold segmentation for PET target volume delineation in radiation treatment planning: the role of target-to-background ratio and target size. Med Phys 2008;35 4:1207–13.PubMedCrossRef

Greco C, Nehmeh SA, Schöder H, Gönen M, Raphael B, Stambuk HE, et al. Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer. Am J Clin Oncol 2008;31 5:439–45.PubMedCrossRef

10.

Benz MR, Allen-Auerbach MS, Eilber FC, Chen HJ, Dry S, Phelps ME, et al. Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas. J Nucl Med 2008;49 10:1579–84.PubMedCrossRef

11.

Vees H, Senthamizhchelvan S, Miralbell R, Weber DC, Ratib O, Zaidi H. Assessment of various strategies for (18)F-FET PET-guided delineation of target volumes in high-grade glioma patients. Eur J Nucl Med Mol Imaging 2008. doi:10.1007/s00259-008-0943-6.

12.

Basu S. Selecting the optimal image segmentation strategy in the era of multitracer multimodality imaging: a critical step for image-guided radiation therapy. Eur J Nucl Med Mol Imaging 2009. doi:10.1007/s00259-008-1033-5.

Titel: SUV and segmentation: pressing challenges in tumour assessment and treatment
verfasst von: Giovanni Lucignani
Publikationsdatum: 01.04.2009
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 4/2009
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-009-1085-1

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2009

Fast and repetitive in-capillary production of [18F]FDG

Society Communications April 09

FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman’s disease

How to use myocardial 123I-MIBG scintigraphy in chronic heart failure

Nuclear imaging in cardiac amyloidosis

Influence of valency and labelling chemistry on in vivo targeting using radioiodinated HER2-binding Affibody molecules